El interés en corto de Bluejay Diagnostics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Bluejay Diagnostics. Los datos de interés en corto se actualizan cada dos semanas.

Bluejay Diagnostics (NASDAQ:BJDX) Bolsa, Informe de interés en corto

Bluejay Diagnostics

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Bluejay Diagnostics Inc

Trading Ideas

HOUR

Hour Loop Shares Halted On Circuit Breaker To The Upside, Stock Now Up 326.6%

Deep-pocketed investors have adopted a bullish approach towards MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MARA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 22 extraordinary options activities for MARA Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 18% bearish. Among these notable options, 10 are puts, totaling $639,202, and 12 are calls, amounting to $540,795.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $7.5 to $50.0 for MARA Holdings over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in MARA Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to MARA Holdings's substantial trades, within a strike price spectrum from $7.5 to $50.0 over the preceding 30 days.
<h3>MARA Holdings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735056942_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.55</td>
<td>$5.55</td>
<td>$5.55</td>
<td>$25.00</td>
<td>$149.8K</td>
<td>18.0K</td>
<td>309</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/27/24</td>
<td>$2.15</td>
<td>$2.09</td>
<td>$2.1</td>
<td>$22.00</td>
<td>$105.0K</td>
<td>3.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.0</td>
<td>$4.7</td>
<td>$5.0</td>
<td>$18.00</td>
<td>$100.0K</td>
<td>2.4K</td>
<td>200</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$7.95</td>
<td>$7.8</td>
<td>$7.86</td>
<td>$25.00</td>
<td>$78.7K</td>
<td>9.3K</td>
<td>102</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.15</td>
<td>$9.1</td>
<td>$9.15</td>
<td>$22.00</td>
<td>$73.2K</td>
<td>991</td>
<td>93</td>
</tr>
</tbody>
</table>

<h3>About MARA Holdings</h3>
MARA Holdings Inc leverages digital asset compute to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value.
After a thorough review of the options trading surrounding MARA Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is MARA Holdings Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 12,463,116, with MARA's price up by 4.35%, positioned at $20.09.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 64 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest MARA Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

MARA

Behind the Scenes of MARA Holdings's Latest Options Trends

Financial giants have made a conspicuous bullish move on Netflix. Our analysis of options history for Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) revealed 39 unusual trades.
Delving into the details, we found 46% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $388,374, and 34 were calls, valued at $2,613,150.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $1180.0 for Netflix over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Netflix stands at 378.18, with a total volume reaching 3,861.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Netflix, situated within the strike price corridor from $5.0 to $1180.0, throughout the last 30 days.
<h3>Netflix 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735056937_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$479.3</td>
<td>$478.2</td>
<td>$478.2</td>
<td>$450.00</td>
<td>$478.2K</td>
<td align="right">91</td>
<td align="right">10</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$66.9</td>
<td>$66.05</td>
<td>$66.55</td>
<td>$920.00</td>
<td>$332.7K</td>
<td align="right">279</td>
<td align="right">57</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$718.6</td>
<td>$717.0</td>
<td>$717.0</td>
<td>$200.00</td>
<td>$215.1K</td>
<td align="right">339</td>
<td align="right">3</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$81.75</td>
<td>$81.4</td>
<td>$81.75</td>
<td>$920.00</td>
<td>$163.5K</td>
<td align="right">114</td>
<td align="right">23</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/03/25</td>
<td>$16.55</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$915.00</td>
<td>$162.8K</td>
<td align="right">221</td>
<td align="right">191</td>
</tr>
</tbody>
</table>

<h3>About Netflix</h3>
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 280 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
After a thorough review of the options trading surrounding Netflix, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Netflix</h3>
<ul>
<li>With a trading volume of 776,020, the price of NFLX is up by 0.98%, reaching $920.38.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 28 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Netflix</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $978.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Netflix, which currently sits at a price target of $1040. 
&#x2A; An analyst from Loop Capital downgraded its action to Hold with a price target of $950. 
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on Netflix, maintaining a target price of $950. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Netflix, which currently sits at a price target of $1010. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Hold rating on Netflix with a target price of $940. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Netflix options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

NFLX

This Is What Whales Are Betting On Netflix

Deep-pocketed investors have adopted a bearish approach towards NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NVDA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 279 extraordinary options activities for NVIDIA. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 43% leaning bullish and 46% bearish. Among these notable options, 26 are puts, totaling $1,945,197, and 253 are calls, amounting to $19,205,178.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $104.0 to $191.0 for NVIDIA during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in NVIDIA's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to NVIDIA's substantial trades, within a strike price spectrum from $104.0 to $191.0 over the preceding 30 days.
<h3>NVIDIA Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735056932_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/27/24</td>
<td>$1.37</td>
<td>$1.36</td>
<td>$1.37</td>
<td>$142.00</td>
<td>$239.0K</td>
<td>33.8K</td>
<td>88.7K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/27/24</td>
<td>$1.38</td>
<td>$1.36</td>
<td>$1.37</td>
<td>$142.00</td>
<td>$164.2K</td>
<td>33.8K</td>
<td>85.6K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$1.04</td>
<td>$1.03</td>
<td>$1.03</td>
<td>$142.00</td>
<td>$144.5K</td>
<td>33.8K</td>
<td>68.8K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/27/24</td>
<td>$1.07</td>
<td>$1.06</td>
<td>$1.07</td>
<td>$142.00</td>
<td>$128.6K</td>
<td>33.8K</td>
<td>79.4K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$1.41</td>
<td>$1.4</td>
<td>$1.4</td>
<td>$142.00</td>
<td>$128.3K</td>
<td>33.8K</td>
<td>94.4K</td>
</tr>
</tbody>
</table>

<h3>About NVIDIA</h3>
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
Following our analysis of the options activities associated with NVIDIA, we pivot to a closer look at the company's own performance.
<h3>Current Position of NVIDIA</h3>
<ul>
<li>Currently trading with a volume of 56,542,252, the NVDA's price is up by 1.1%, now at $141.21. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 64 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NVIDIA options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

NVDA

NVIDIA Unusual Options Activity For December 24

AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) has outperformed the market over the past 10 years by 2.21% on an annualized basis producing an average annual return of 13.39%. Currently, AECOM has a market capitalization of $14.30 billion. 
Buying $1000 In ACM: If an investor had bought $1000 of ACM stock 10 years ago, it would be worth $3,500.81 today based on a price of $107.92 for ACM at the time of writing.
<h3>AECOM's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735056912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Here's How Much You Would Have Made Owning AECOM Stock In The Last 10 Years

WULF

TeraWulf Option Alert: Jan 17 $8 Calls Sweep (8) Near The Ask: 3233 @ $0.295 vs 27353 OI; Ref=$6.295

After beating most assets in 2024, gold is poised to continue its bullish trajectory. While positive catalysts like central bank purchases and inflation concerns still loom, the market sees President-elect Donald Trump's second term as a <a href="https://www.benzinga.com/markets/commodities">major volatility driver</a>.
&#8220;Although gold's momentum stalled in November as Donald Trump's win at the polls drove a surge in risk assets and the U.S. dollar, we think its price still has room to run in 2025,&#8221;<a href="https://www.ssga.com/au/en_gb/institutional/insights/gold-2025-outlook-more-room-to-run"> noted</a> State Street Global Advisors, an investment management division of the world's fourth largest asset manager.
Among their gold strength catalysts are robust central bank demand, growing consumer investment in Asia, and the fiscal and monetary uncertainty stemming from Trump's anticipated policies. "Gold remains an essential hedge against rising inflation, geopolitical instability, and potential currency devaluations," the firm stated.
Trump's second term, set to begin on Jan. 20, is expected to intensify market volatility. Tariff policies could stoke cost-push inflation, particularly the threat of up to 60% tariffs on Chinese imports. These tariffs would likely pressure the U.S. dollar, making gold an attractive hedge, State Street said.
In contrast, a strong dollar—buoyed by higher interest rates or foreign asset flows—could temper gold's gains (owing to the historical inverse relationship). However, central bank purchases may offset this effect.
Since 2022, central banks have <a href="https://www.benzinga.com/markets/asia/24/05/38649656/how-chinas-central-bank-gold-buying-frenzy-drove-prices-to-record-highs-attracting-gen-z-to-gold-bea">purchased 2,700 tons of gold</a>, the fastest pace in recent history, reflecting a deliberate move to diversify away from dollar-heavy reserves. Emerging markets, in particular, have accelerated de-dollarization efforts as geopolitical tensions rise. For example, India significantly expanded its gold reserves. Cultural significance, increased investment options like ETFs, and favorable tax reforms have bolstered demand.
Drawing historical parallels, State Street sees Trump's policies—marked by tax cuts, increased defense spending, and tariff strategies—as comparable to George W. Bush's tenure, during which gold rallied 221% amid growing federal debt and accommodative monetary policies.
State Street projects three scenarios for gold in 2025:
<ul>
<li>Base Case (50% Probability): $2,600-$2,900/oz. Robust central bank purchases and steady Asian demand maintain a soft price floor.</li>
<li>Bull Case (30% Probability): $2,900-$3,100/oz. Weaker dollar and Fed rate cuts spur ETF inflows and bolster Asian demand.</li>
<li>Bear Case (20% Probability): $2,200-$2,600/oz. Strong US growth and dollar strength lead to ETF outflows, though central bank buying provides support.</li>
</ul>
State Street's specialized gold ETF, SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), is up 26.04% year-to-date.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/12/42645035/reviewing-benzingas-mining-watchlist-for-2024">Reviewing Benzinga&#8217;s Mining Watchlist For 2024</a></li>
</ul>
Image created using photos from Shutterstock.

Sector ETFs

Price Target

Commodities

Analyst Ratings

ETFs

Why Trump's Return To Office Could Drive Gold Demand In 2025

Raymond James analyst Stephen Boland maintains Payfare (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PAY#TSX">PAY</a>) with a Market Perform and raises the price target from C$3 to C$4.

TSX:PAY

Raymond James Maintains Market Perform on Payfare, Raises Price Target to C$4

AVGR

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 197.3%

Avinger Shares Resume Trading

<a href="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9" title="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9">https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9</a>

Avinger Awarded U.S. Patent 'US 12171407 B2' For 'ATHERECTOMY CATHETER DRIVE ASSEMBLIES'

<a href="https://www.benzinga.com/personal-finance/24/09/40985018/mark-cubans-black-amex-card-was-declined-trying-to-buy-a-140-000-bottle-of-champagne-after-his-n">Billionaire Mark Cuban</a> shared some candid insights about parenting on The Steam Room Podcast in November, hosted by Charles Barkley and Ernie Johnson. When Barkley asked Cuban how he avoids spoiling his kids despite his massive fortune, Cuban responded with a phrase that's as sharp as it is simple: "It's my money, not yours."
It's a sentiment echoed by other wealthy parents, like Shaquille O'Neal, who famously said, <a href="https://www.benzinga.com/personal-finance/24/09/40943843/we-aint-rich-im-rich-nba-legend-shaq-says-his-daughters-and-sons-dont-get-equal-treatment-my-boy">"We ain't rich, I'm rich"</a> and Bill and Melinda Gates, who emphasized a "<a href="https://www.benzinga.com/personal-finance/24/07/40015377/bill-gates-children-will-only-inherit-10-million-0-0077-of-his-net-worth-leaving-kids-massive-am">middle-class upbringing</a>" for their kids. But Cuban's take feels especially personal when you hear how he talks about his three kids.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
"You know what it's like," Cuban told Barkley. "Your kids – no, you think they're going to be like you and your wife, but they end up being their own little humans." He described his children&#8217;s unique personalities: "One takes advantage, the other two don't. The middle one rebels against it … and my son, the youngest, takes advantage a little bit of tech because he knows I'll give in."
Even so, Cuban insists on keeping things grounded at home. "They still have to wash dishes, they still have to clean up after themselves – most of the time," he said. While he acknowledges that it's not easy – "They're getting on a private plane most of the time and it's not like we can hide it from them" – he's determined to avoid the trap of throwing material things at them as a solution. "You're mad at me? Let me buy you something. You're sad? Let me buy you something. That's just not how it works."
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
The conversation feels refreshingly human, especially coming from someone whose life seems anything but ordinary. It's one thing to talk about discipline when your kids are flying coach, but Cuban's perspective shows that the challenges of raising "grateful and great human beings," as Barkley put it, exist at every level.
It's a mindset shared by other high-profile figures like Shaq, who requires his kids to earn two degrees before they can access his wealth. The underlying principle? Wealth shouldn't define your kids but challenge them to find their paths.
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Back in 2014, Mark Cuban <a href="https://www.benzinga.com/personal-finance/24/10/41433888/dave-ramsey-tells-mark-cuban-regardless-of-socio-economic-status-you-have-to-teach-kids-to-work">appeared on The Dave Ramsey Show</a> and opened up about teaching kids the value of hard work. He also shared some of his biggest concerns as a parent. "Their health is number one, my number one fear and then just not being jerks is number two," Cuban said.
Mark Cuban's honesty about his parenting style – <a href="https://www.benzinga.com/money/are-you-rich">balancing privilege with responsibility – </a>might not be a one-size-fits-all solution, but it's clear he's trying to do more than just raise rich kids. He's raising adults.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>

Personal Finance

Billionaire Mark Cuban Says He Doesn't Spoil His Kids And Tells Them 'It's My Money, Not Yours'

Illumina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) has outperformed the market over the past 20 years by 10.11% on an annualized basis producing an average annual return of 18.44%. Currently, Illumina has a market capitalization of $21.57 billion. 
Buying $100 In ILMN: If an investor had bought $100 of ILMN stock 20 years ago, it would be worth $2,976.69 today based on a price of $135.99 for ILMN at the time of writing.
<h3>Illumina's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735056016_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ILMN

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years

In the current session, the stock is trading at $113.82, after a 0.65% spike. Over the past month, Arista Networks Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) stock increased by 11.50%, and in the past year, by 91.51%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1735056007_0.png" alt="Past Year Chart" />

<h3>Comparing Arista Networks P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Arista Networks has a better P/E ratio of 54.3 than the aggregate P/E ratio of 49.32 of the Communications Equipment industry. Ideally, one might believe that Arista Networks Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1735056007_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

ANET

P/E Ratio Insights for Arista Networks

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 164.6%

SoundHound AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares are trading lower on Tuesday, pulling back from recent strength. The rally accelerated in November when the company reported strong earnings. Here&#8217;s what you <a href="https://www.benzinga.com/tech/24/12/42628373/exclusive-soundhound-ai-ceo-on-882-growth-were-just-getting-started">need to know</a>.
What To Know: SoundHound shares are up more than 875% since the start of the year, buoyed by the company&#8217;s positioning in the AI space. The stock has nearly tripled since mid-November when the company reported better-than-expected quarterly results, marking its &#8220;largest quarter on record.&#8221;
SoundHound reported a third-quarter loss of 6 cents per share, beating estimates of a loss of 7 cents per share. The company reported revenue of $25.1 million, beating estimates of $23.02 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. SoundHound said demand was driven by &#8220;incredible market enthusiasm&#8221; for conversational AI tools.
SoundHound shares continued to move higher following earnings after Nvidia reported investments in multiple companies, including SoundHound, in a 13-F filing with the SEC. Nvidia&#8217;s 13F <a href="https://www.sec.gov/Archives/edgar/data/1045810/000104581024000305/xslForm13F_X02/information_table.xml">latest filing</a> showed that it increased its stake in SoundHound by about 18% in the third quarter.
Analysts lifted price targets as the stock has continued to trend higher. Last Week, Wedbush analyst Dan Ives maintained SoundHound with an <a href="https://www.benzinga.com/analyst-stock-ratings">Outperform</a> rating and raised its price target from $10 to $22. On Monday, HC Wainwright &amp; Co. analyst Scott Buck maintained a Buy rating on the stock and raised its price target from $8 to $26.
See Also: <a href="https://www.benzinga.com/news/large-cap/24/12/42668623/american-airlines-resolves-nationwide-flight-grounding-on-christmas-eve-shares-rebound-after-brief-selloff">American Airlines Lifts Christmas Eve Grounding, Shares Bounce Back</a>
It&#8217;s worth noting that SoundHound has high short interest with 24.4% of the float currently sold short, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>. SoundHound has also been showing up on Benzinga&#8217;s <a href="https://www.benzinga.com/trading-ideas/24/12/42628286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-including-qubt-qbts">Stock Whisper Index</a> in recent weeks. 
In an exclusive interview on Friday, SoundHound CEO Keyvan Mohajer told Benzinga that AI has moved from the exploratory phase to the mandatory phase for budgets.
&#8220;In that context, SoundHound is in a prime position. Our ability to combine proprietary voice AI technology with sophisticated large language models has allowed us to deliver immense value,&#8221; Mohajer said. 
The SoundHound CEO told Benzinga that the company is powering hundreds of global enterprise brands, thousands of restaurant and retail locations and millions of vehicles and devices.
&#8220;And we&#8217;re just getting started,&#8221; Mohajer said.
SOUN Price Action: <a href="http://benzinga.com/quote/soun">SoundHound shares</a> were flat at 0.34% at $20.45 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/24/12/42628286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-including-qubt-qbts">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet, Including QUBT, QBTS</a></li>
</ul>
Photo: Shutterstock.

Movers

SOUN

What's Going On With SoundHound AI Stock?

Avinger Shares Resume Trade

HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) announced on Tuesday its acquisition and deployment of advanced Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) H100 and H200 GPU clusters <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/42665811/hive-expands-nvidia-chip-suite-to-power-ai-boom-with-30-million-h100-and-h200-gpu-clusters-to-be-de" rel="noreferrer noopener">in Quebec, Canada</a>.
This strategic $30 million investment aims to strengthen HIVE&#8217;s position in artificial intelligence (AI) and high-performance computing (HPC) and enhance its role in the digital transformation landscape.
The new GPU clusters are part of HIVE&#8217;s broader strategy to drive growth in AI and HPC markets.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/24/12/42613368/broadcom-expects-decade-long-ai-chip-boom-as-big-tech-invest-billions" rel="noreferrer noopener">Broadcom Expects Decade-Long AI Chip Boom as Big Tech Invest Billions</a>
HIVE expects the latest technology to significantly boost its annualized run-rate revenue and margin growth in the coming quarters.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24062648/newplot-14.png" alt="" class="wp-image-705809" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24062648/newplot-14.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/24062648/newplot-14-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
The Nvidia H100 cluster, consisting of 248 GPUs across 32 nodes, is fully configured and set to be operational by the end of 2024. Once deployed, this cluster will likely generate ~$15 million in annualized run-rate revenue.
The Nvidia H200 cluster, featuring 508 GPUs in 64 nodes, is scheduled to arrive in early January 2025 and be deployed in the first quarter of 2025.
HIVE projects over $20 million in annualized run-rate revenue from the H200 cluster by the second quarter of 2025.
Aligned with its commitment to sustainability, HIVE powers its operations in Quebec entirely with renewable energy.
In October, Cantor Fitzgerald&#8217;s Brett Knoblauch <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41603920/hive-pushes-hash-rate-higher-sharpens-focus-on-ai" rel="noreferrer noopener">highlighted HIVE&#8217;s measured</a> approach to growth, contrasting it with peers focusing on aggressive expansion.
He noted that the company prioritizes maximizing returns from fleet investments over rapid scaling, which has led to underperformance relative to competitors.
The analyst expects HIVE to double its hash rate in the coming year while maintaining its top-tier mining efficiency. He also pointed out HIVE&#8217;s advancements in AI and high-performance computing (HPC), emphasizing the potential of its GPU cloud platform, HIVE Cloud.
HIVE&nbsp;stock plunged over 32% year-to-date.
Price Actions:&nbsp;HIVE stock is up 2.69% at $3.05 at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42621868/nvidia-secures-eu-approval-for-runai-deal-us-probes-china-export-breach" target="_blank" rel="noreferrer noopener">Nvidia Secures EU Approval For Run:ai Deal, US Probes China Export Breach</a></li>
</ul>
Photo by rafapress via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

HIVE

HIVE Digital Boosts AI Ambitions With $30 Million Nvidia GPU Deployment

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 128.8%

Strategic location offers unique opportunity to ensure reliability for the New England region and advance Massachusetts&#39; clean energy transition by interconnecting multiple renewable energy sources
With a focus on helping to enable Massachusetts&#39; unprecedented clean energy transition while ensuring safe, reliable service for customers across New England, Eversource has acquired a 26-acre portion of the Mystic property from Constellation Energy. Eversource has not developed specific plans for the site at this time, but its strategic location, historic use, and existing infrastructure uniquely position it as a potential multi-use energy interconnection hub for large-scale renewable energy sources &ndash; including onshore or offshore wind, hydro, battery storage and nuclear among others &ndash; with the capacity to support electrification and meet the reliability needs for major energy users in the region. Over the coming year, Eversource will collaborate closely with Massachusetts and Everett officials and other stakeholders to develop a plan for the property, which is adjacent to the site of the proposed soccer stadium in Everett, to improve electric reliability in New England while also helping to advance Massachusetts&#39; electrification and decarbonization goals.

Eversource Acquires Mystic Property From Constellation Energy; No Financial Terms Disclosed

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) just reported results for the fourth quarter of 2023.<ul><li>Bluejay Diagnostics reported earnings per share of -$1.78. This was below the analyst estimate for EPS of -68 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/bjdx-stock-earnings-bluejay-diagnostics-for-q4-of-2023/">BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023

Bluejay Diagnostics (BJDX) has issued an announcement. Bluejay Diagnostics, Inc. has ended its agreement with DLA, LLC, leading to the departure of...

Bluejay Diagnostics Announces CFO Change and Stockholders' Meeting Date

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about!



Moving shares are earnings reports, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chicken Soup for the Soul (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) stock is rocketing more than 68% alongside heavy pre-market trading.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are soaring over 26% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318251841&amp;type=PDF&amp;symbol=ZPTA&amp;cdn=84fce7fb704e6ef8a8fd234dc0d1a286&amp;companyName=Zapata+Computing+Holdings+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-04-24">secondary offering news</a>.</li>



<li>GraniteShares 2x Long TSLA Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLR#NASDAQ">TSLR</a>) stock is surging close to 24% following Tesla&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) <a href="https://www.marketwatch.com/livecoverage/tesla-earnings-ev-elon-musk-q1-stock-cybertruck-robotaxi/">latest earnings report</a>.</li>



<li>T-REX 2X Long Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslt-stock-quote/">TSLT</a>) shares are gaining more than 22% for the same reason. </li>



<li>Direxion Daily TSLA Bull 2X Shares (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsll-stock-quote/">TSLL</a>) stock is rising over 22% alongside TSLA earnings.</li>



<li>XBP Europe (NASDAQ:<a href="https://investorplace.com/stock-quotes/xbp-stock-quote/">XBP</a>) shares are increasing more than 22% without any clear news this morning.</li>



<li>B. Riley Financial (NASDAQ:<a href="https://investorplace.com/stock-quotes/rily-stock-quote/">RILY</a>) stock is climbing over 19% with the release of its <a href="https://www.prnewswire.com/news-releases/b-riley-financial-files-2023-annual-report-on-form-10-k-302125970.html">2023 annual report</a>.</li>



<li>Vertiv (NYSE:<a href="https://investorplace.com/stock-quotes/vrt-stock-quote/">VRT</a>) shares are heading more than 16% higher after <a href="https://www.investors.com/news/vertiv-spikes-on-earnings-ai-stocks-nvidia-super-micro/">releasing its Q1 earnings report</a>.</li>



<li>AudioEye (NASDAQ:<a href="https://investorplace.com/stock-quotes/aeye-stock-quote/">AEYE</a>) stock is getting an over 13% boost with its <a href="https://qz.com/audioeye-q1-earnings-snapshot-1851430210">Q1 earnings release</a>.</li>



<li>WiMi Hologram Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>) shares are up more than 13% following a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318249494&amp;type=PDF&amp;symbol=WIMI&amp;cdn=21b188804ad8e2afae8ca53a0c6f207e&amp;companyName=WiMi+Hologram+Cloud+Inc.&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-23">goodwill impairment assessment</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Evotec (NASDAQ:<a href="https://investorplace.com/stock-quotes/evo-stock-quote/">EVO</a>) shares are plummeting more than 35% alongside its <a href="https://www.nasdaq.com/press-release/evotec-presents-fiscal-year-2023-results-and-announces-priority-reset-to-focus-on">latest earnings report</a>.</li>



<li>Fabrinet (NYSE:<a href="https://investorplace.com/stock-quotes/fn-stock-quote/">FN</a>) stock is diving over 24% after <a href="https://www.nasdaq.com/press-release/fabrinet-to-announce-third-quarter-fiscal-year-2024-financial-results-on-may-6-2024">announcing its earnings date</a>.</li>



<li>GraniteShares 2x Short TSLA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsdd-stock-quote/">TSDD</a>) shares are dropping more than 23% after TSLA&rsquo;s earnings report.</li>



<li>T-Rex 2X Inverse Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslz-stock-quote/">TSLZ</a>) stock is falling over 23% for the same reason.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) shares are sliding 20% without any clear news.</li>



<li>Kiora Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/kprx-stock-quote/">KPRX</a>) stock is decreasing more than 19% today.</li>



<li>Mawson Infrastructure (NASDAQ:<a href="https://investorplace.com/stock-quotes/migi-stock-quote/">MIGI</a>) shares are slipping nearly 16% on Wednesday morning.</li>



<li>Applied DNA Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/apdn-stock-quote/">APDN</a>) stock is dipping over 15% ahead of a <a href="https://www.nasdaq.com/press-release/applied-dna-announces-1-for-20-reverse-stock-split-2024-04-22">reverse stock split tomorrow</a>.</li>



<li>BiomX (NYSEMKT:<a href="https://investorplace.com/stock-quotes/phge-stock-quote/">PHGE</a>) shares are declining more than 14% <a href="https://www.nasdaq.com/press-release/biomx-to-present-data-from-phase-1b-2a-study-of-bx004-for-the-treatment-of-cystic">following a rally yesterday</a>.</li>



<li>Ostin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ost-stock-quote/">OST</a>) stock closes out our pre-market stock movers down over 11%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-april-24th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders will want to read about on Monday morning!



Moving stocks this morning an investor update, clinical trial news, a private offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Scinai Immunotherapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/">SCNI</a>) stock is rocketing more than 69% alongside heavy pre-market trading.</li>



<li>Schmid Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/shmd-stock-quote/">SHMD</a>) shares are soaring 40% without any clear news this morning.</li>



<li>ENDRA Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/">NDRA</a>) stock is surging over 36% alongside an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318395592&amp;type=PDF&amp;symbol=NDRA&amp;cdn=4506ae3b1a739822361489bedc53ef84&amp;companyName=ENDRA+Life+Sciences+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-06-14">investor stake update</a>.</li>



<li>Maxeon Solar Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/">MAXN</a>) shares are rising more than 21% with strong early morning trading.</li>



<li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) stock is increasing over 18% as it continues to <a href="https://investorplace.com/2024/06/why-is-srivaru-svmh-stock-up-122-today/">rally on e-bike news</a>.</li>



<li>Nurix Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrix-stock-quote/">NRIX</a>) shares are gaining 17% on <a href="https://www.marketwatch.com/story/nurix-therapeutics-shares-rise-on-positive-leukemia-drug-results-66b9d524?mod=investing">positive drug results</a>.</li>



<li>Icecure Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/iccm-stock-quote/">ICCM</a>) stock is getting a 14% boost with it still rallying on <a href="https://www.nasdaq.com/press-release/positive-data-icecures-kidney-cancer-clinical-study-presented-interventional">kidney cancer study data</a>.</li>



<li>Kineta (NASDAQ:<a href="https://investorplace.com/stock-quotes/ka-stock-quote/">KA</a>) shares are heading more than 13% higher with heavy trading today.</li>



<li>XTL Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/">XTLB</a>) stock is jumping over 12% this morning.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) shares are up more than 11% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is plummeting more than 35% after a massive rally on Friday.</li>



<li>Sonim Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sonm-stock-quote/">SONM</a>) shares are diving over 25% this morning.</li>



<li>AMC Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/amcx-stock-quote/">AMCX</a>) stock is tumbling more than 23% after <a href="https://www.nasdaq.com/press-release/amc-networks-inc-announces-private-offering-125-million-convertible-senior-notes-2024">announcing a private offering</a>.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) shares are taking an over 17% beating despite a lack of news.</li>



<li>Northann (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ncl-stock-quote/">NCL</a>) stock is falling close to 14% without any news to report.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) shares are dropping more than 13% as it <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">comes off a rally last week</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) stock is decreasing over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396271&amp;type=PDF&amp;symbol=APVO&amp;cdn=21e6c068c48621c307f0f74bc8553007&amp;companyName=Aptevo+Therapeutics+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-14">proposed public offering</a>.</li>



<li>Feutune Light Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/flfv-stock-quote/">FLFV</a>) shares are slipping almost 12% on Monday.</li>



<li>Volcon (NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) stock is dipping more than 11% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396398&amp;type=PDF&amp;symbol=VLCN&amp;cdn=980b1d9c3f018f25ac11de4d0e102b66&amp;companyName=Volcon+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-14">a delisting notice</a>.</li>



<li>Holdco Nuvo (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuvo-stock-quote/">NUVO</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Bluejay Diagnostics announces 1-for-8 reverse stock split

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Thursday as we dig into all of the news moving shares this morning!



Moving stocks are public offering updates, new investments an earnings report and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock is rocketing more than 128% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318417463&amp;type=PDF&amp;symbol=IONM&amp;cdn=8d8708e472ad2a1117d6e2e1ea234033&amp;companyName=Assure+Holdings+Corp.&amp;formType=RW&amp;formDescription=Registration+Withdrawal+Request&amp;dateFiled=2024-06-26">withdrawing a proposed public offering</a>.</li>



<li>Vigil Neuroscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/vigl-stock-quote/">VIGL</a>) shares are soaring over 40% on a <a href="https://www.globenewswire.com/news-release/2024/06/27/2904902/0/en/Vigil-Neuroscience-Announces-40-Million-Strategic-Investment-from-Sanofi.html">$40 million investment</a>.</li>



<li>CASI Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/casi-stock-quote/">CASI</a>) stock is surging more than 31% on a <a href="https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-15-million-private-placement-financing-by-venrock-healthcare-capital-partners-foresite-capital-panacea-venture-and-dr-wei-wu-he-302183230.html">$15 million private placement</a>.</li>



<li>Entero Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ento-stock-quote/">ENTO</a>) shares are gaining over 26% on a <a href="https://www.nasdaq.com/press-release/entero-therapeutics-announces-peer-reviewed-publication-unveiling-novel-algorithm">peer-reviewed publication</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is increasing more than 24% as it <a href="https://investorplace.com/2024/06/faraday-future-ffie-stock-soars-80-following-rivian-volkswagen-deal/">continues a recent rally</a>.</li>



<li>Incannex Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/ixhl-stock-quote/">IXHL</a>) shares are jumping over 23% despite a lack of news this morning.</li>



<li>Geovax Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/">GOVX</a>) stock is climbing more than 21% without any clear news this morning.</li>



<li>Fresh Vine Wine (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vine-stock-quote/">VINE</a>) shares are heading close to 17% higher with heavy pre-market trading.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is getting an over 15% boost without any obvious news to report.</li>



<li>Hyzon Motors (NASDAQ:<a href="https://investorplace.com/stock-quotes/hyzn-stock-quote/">HYZN</a>) shares are up nearly 15% with strong trading this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Branchout Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) stock is plummeting more than 37% after <a href="https://www.nasdaq.com/press-release/branchout-food-prices-14-million-follow-public-offering-2024-06-26">pricing a follow-on offering</a>.</li>



<li>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) shares are diving over 28% on a <a href="https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-proposed-public-d6yhuinwfxm9.html">proposed public offering</a>.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) stock is tumbling more than 21% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318418078&amp;type=PDF&amp;symbol=BJDX&amp;cdn=14a15ef82de2ebc313ddbbf7cad3f31c&amp;companyName=Bluejay+Diagnostics+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-06-26">effecting a public offering</a>.</li>



<li>Immutep (NASDAQ:<a href="https://investorplace.com/stock-quotes/immp-stock-quote/">IMMP</a>) shares are taking an over 17% beating without any apparent news today.</li>



<li>VSee Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock is slipping more than 17% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318417950&amp;type=PDF&amp;symbol=VSEE&amp;cdn=a8750adb0a7c7d12db86db6bfac8e49b&amp;companyName=VSee+Health+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-26">alongside recent insider trading</a>.</li>



<li>Swvl (NASDAQ:<a href="https://investorplace.com/stock-quotes/swvl-stock-quote/">SWVL</a>) shares are dropping over 16% on Thursday morning.</li>



<li>Levi Strauss (NYSE:<a href="https://investorplace.com/stock-quotes/levi-stock-quote/">LEVI</a>) stock is decreasing more than 16% with its <a href="https://www.cnbc.com/2024/06/26/levi-levi-earnings-q2-2024.html">Q2 earnings report</a>.</li>



<li>International Paper (NYSE:<a href="https://investorplace.com/stock-quotes/ip-stock-quote/">IP</a>) shares are falling over 15% today.</li>



<li>Recursion Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/rxrx-stock-quote/">RXRX</a>) stock is slipping more than 14% after <a href="https://www.stocktitan.net/news/RXRX/recursion-announces-pricing-of-200-million-public-offering-of-class-49il22g17787.html">pricing a public offering</a>.</li>



<li>KraneShares California Carbon Allowance Strategy ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/kcca-stock-quote/">KCCA</a>) shares close out our pre-market stock movers down over 13%. </li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-june-27th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) just reported results for the second quarter of 2024.<ul><li>Bluejay Diagnostics reported earnings per share of -$5.12. This was below the analyst estimate for EPS of -72 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/bjdx-stock-earnings-bluejay-diagnostics-for-q2-of-2024/">BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q2 2024

Bluejay Diagnostics announces 1 for 50 reverse stock split

Bluejay Diagnostics (BJDX) announced that the company's Board of Directors has approved a reverse stock split of its shares of common stock at a ra...

Bluejay Diagnostics announces 1-for-50 reverse stock split

19:50 EST Bluejay Diagnostics (BJDX) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...

Bluejay Diagnostics Inc trading halted, news pending

AEYE

AMCX

APDN

APVO

BJDX

CASI

CONN

CSSE

ENTO

FFIE

FLFV

GOVX

HYZN

ICCM

IMMP

IONM

IXHL

KAVL

KCCA

KPRX

LEVI

MAXN

MIGI

NDRA

NRIX

NUVO

PHGE

PHUN

RILY

RXRX

SCNI

SHMD

SONM

SVMH

SWVL

TNXP

TSDD

TSLA

TSLL

TSLR

TSLT

TSLZ

VIGL

VINE

VLCN

VSEE

WIMI

XTLB

ZAPP

ZPTA

Press Releases

General

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Financing

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Reverse Stock Split

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Bitech Technologies (OTCQB: BTTC) Appoints Montgomery Bannerman to Drive Strategic Growth in Renewable Energy – see other stocks inside….

Comments

Bluejay Diagnostics

Interés en corto

Bluejay Diagnostics (NASDAQ:BJDX) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL